MSTN and sarcopenia: A study by Li et al. indicated that among patients with T2DM, myostatin levels were significantly higher in subjects with sarcopenia [114]; however, the study only included 34 sarcopenic individuals (meeting the criteria of the Asian sarcopenia diagnostic consensus).